Business Relations Table - o4.fyi ()

Anmelden Gast|Guest
Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

Domain-Statistiken für "celltrion.com"

439
Business Relations
379
Eindeutige Domains
20
Gefundene Einträge
BR-Relations: 439
From Domain Role To Domain Path Aktionen
/portfolio/client/
/global/celltrion/
/celltrion-to-present-seven-abstracts-in-inflammatory-bowel-disease-ibd-at-2026-digestive-disease-week-ddw/
/
/fda-approves-expanded-indication-for-avtozma-tocilizumab-anoh-intravenous-iv-formulation-in-cytokine-release-syndrome-crs/
/fda-approves-expanded-indication-for-avtozma-tocilizumab-anoh-intravenous-iv-formulation-in-cytokine-release-syndrome-crs/
/
/celltrion-launches-actemra-biosimilar-avtozma/
/celltrion-announces-korean-approval-of-biosimilar-monoclonal-antibody/
/fda-approves-expanded-pediatric-indications-for-yuflyma-adalimumab-aaty-and-unbranded-adalimumab-aaty-in-the-united-states/
/novo-medicamento-tratar-cancer-mama-aprovado/
/open-doors-to-the-asian-market-seoul-bio-hub-celltrion-launches-global-open-innovation-for-u-s-startups/
/view/Portfolio:COVID-19_Testing,_Reporting,_and_Information_Management_in_the_Laboratory/Adding_COVID-19_and_other_virus_testing_to_your_laboratory
/noticias-salud/skin-health/cuales-son-los-mejores-tratamientos-para-la-urticaria-cronica
/celltrion-announces-u-s-fda-approval-of-additional-presentation-of-steqeyma-ustekinumab-stba-expanding-dosing-options-for-pediatric-patients/
/post/autoimmune-summaries-17th-march-2026
/tnf-inhibitors-market-15520
/
/index.php/journal/article/view/400
/pr-news/celltrions-steqeyma-ustekinumab-stba-now-added-to-the-costco-member-prescription-program